The Human Monoclonal anti-ANGPTL3 (Evinacumab Biosimilar) antibody has been validated for . It is suitable to detect ANGPTL3 (Evinacumab Biosimilar) in samples from Human.
Catalog No. ABIN7597678
Quick Overview for Recombinant ANGPTL3 (Evinacumab Biosimilar) antibody (ABIN7597678)
Target
ANGPTL3 (Evinacumab Biosimilar)
Antibody Type
Recombinant Antibody
Reactivity
Human
Host
Human
Clonality
Monoclonal
Conjugate
This ANGPTL3 (Evinacumab Biosimilar) antibody is un-conjugated
Application
Please inquire
Grade
Research Grade
Expression System
Mammalian cells
Purpose
Research Grade Evinacumab Biosimilar Antibody
Specificity
ANG-5, Angiopoietin-like protein 3, ANGPT5, Angiopoietin-5, ANGPTL3, Angiopoietin-related protein 3
Purification
Protein A or G purified from cell culture supernatant.
Research Grade
Reactivity: Human
Host: Mammalian Cells
Monoclonal
unconjugated
Recombinant Antibody
Restrictions
For Research Use only
Format
Liquid
Concentration
1.35 mg/mL
Buffer
0.01M PBS, pH 7.4.
Storage
4 °C,-20 °C,-80 °C
Storage Comment
Use a manual defrost freezer and avoid repeated freeze-thaw cycles.Store at +4°C short term (1-2 weeks).Store at -20 °C 12 months. Store at -80°C long term.
Expiry Date
12 months
Target
ANGPTL3 (Evinacumab Biosimilar)
Alternative Name
Evinacumab Biosimilar
Target Type
Biosimilar
Background
ANG-5, Angiopoietin-like protein 3, ANGPT5, Angiopoietin-5, ANGPTL3, Angiopoietin-related protein 3